Related Experiment Video
Updated: Jan 2, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Type I interferons and dendritic cells in cancer immunotherapy
Jenny Sprooten1, Patrizia Agostinis2, Abhishek D Garg1
1Cell Death Research & Therapy (CDRT) Unit, Department for Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Type I interferons (IFNs) enhance cancer immunity and therapy effectiveness. Dendritic cells (DCs) are crucial for this IFN-driven response, impacting cancer immunotherapy success.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Type I interferons (IFNs) are critical for cancer immunosurveillance and boosting conventional and immunotherapies.
- Dendritic cells (DCs) are key players in mediating type I IFN-driven anti-tumor immunity.
Purpose of the Study:
- To elucidate the intricate relationship between type I IFNs and DCs in cancer biology.
- To explore the mechanisms of type I IFN production and their influence on DC-mediated anti-cancer immunity.
- To discuss the implications for developing novel cancer immunotherapies, including DC-based vaccines.
Main Methods:
- Review of preclinical and clinical evidence on type I IFNs and DCs in cancer.
- Analysis of mechanisms of type I IFN production.
- Evaluation of type I IFN impact on DC function and anti-cancer immunity.
Main Results:
- Type I IFNs significantly enhance cancer immunosurveillance and the efficacy of various cancer treatments.
- DC responsiveness to type I IFNs is essential for successful anti-cancer therapy.
- Understanding these interactions informs the development of immunotherapies.
Conclusions:
- The interplay between type I IFNs and DCs is fundamental to anti-cancer immunity.
- Targeting type I IFN pathways and enhancing DC function holds promise for improving cancer immunotherapy outcomes.
- This review highlights the potential of type I IFN-centric strategies, including DC vaccines, for cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

